New evidence links vitamin D status with cognition in patients with psychosis.Related content:Risk Factors for Suicidality in Patients With Schizophrenia ©R_Szatkowski/Shutterstock
Digitally Tracking Patients With Schizophrenia: The Future Is Here
What does the evidence tell us about digital sensors for treatment adherence in patients with schizophrenia and other psychiatric disorders?
Tardive Dyskinesia Quiz: Scales, Syndromes, and Spontaneity
Tardive syndromes include a broad spectrum of abnormal movements. Which movement disorders can resemble tardive dyskinesia? Find out in the quiz.
Treating the Sickest: Why Does the US Lag Behind?
How to decrease recidivism for individuals with serious mental illnesses who are released from jails or prisons or discharged from hospitals? Here are several effective mechanisms.
Risk Factors for Suicidality in Patients With Schizophrenia
What are the strongest predictors of suicidality in schizophrenia?
Vitamin D Deficiency and Cognitive Functioning in Psychotic Disorders
New evidence links vitamin D status with cognition in patients with psychosis.
Transcranial Magnetic Stimulation and Schizophrenia
This article describes challenges for psychiatrists striving to ensure informed consent for, and for patients who may lack full appreciation of the risks and benefits of, neurostimulation.
Mechanisms of Tardive Dyskinesia: 3-Question Quiz
Which genes have recently been associated with TD? That question and more in this quiz.
Putting a Face on Serious Mental Illness
In recent years, violence has unfortunately become the tragic touchstone that too often draws the public’s attention to mental illness.
Marijuana—Legal, But Not by Prescription
What are the pros and cons of marijuana use? Dr Andrew Saxon gives his viewpoint on why he is against medical marijuana but in favor of legalization of recreational use of marijuana.
New Psychopharmacology Algorithms
Dr David Osser offers compelling reasons why you might want to take a look at these 7 algorithms, each of which offers actionable consultations—usually in under 2 minutes.
New Research in the Genetics of Autism
An expert discusses the clinical, biological, and genetic components of de novo mutations and autism spectrum disorders.
8 Reasons a Psychotropic Medication May Be Discontinued
Tips for having a balanced and comprehensive risk-to-benefit discussion with competent patients who want to stop their medications.
A New Drug in Development for Negative Symptoms
Is an effective, well-tolerated treatment for the negative symptoms of schizophrenia on the horizon?
The Gut Microbiome in First-Episode Psychosis
New findings support the involvement of microbiota alterations in psychosis—and point to novel treatments.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.